Heartburn drug being studied as COVID-19 treatment
By Rebecca Klar - 04/27/20 07:31 AM EDT
A heartburn drug is being studied as a possible treatment for COVID-19 patients in New York hospitals, officials confirmed on Monday.
The clinical trial regarding famotidine, the active ingredient in Pepcid, is being conducted by the Feinstein Institutes for Medical Research, the research arm of Northwell Health, which runs a network of 23 hospitals in the New York City area.
More than 150 people are enrolled in the study, Northwell confirmed to The Hill.
Results of the trial could be out in the next few weeks, according to CNN, which first reported the study.
more
https://thehill.com/policy/healthcare/494760-heartburn-drug-being-studied-as-covid-19-treatment
